Doxazosin in the treatment of mild or moderate essential hypertension: An echocardiographic study
- 31 January 1991
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 121 (1), 352-356
- https://doi.org/10.1016/0002-8703(91)90871-e
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- An open one-year comparison of doxazosin and prazosin for mild to moderate essential hypertensionThe American Journal of Cardiology, 1987
- Plasma lipid lowering effects of doxazosin, a new selective alpha1 adrenergic inhibitor for systemic hypertensionThe American Journal of Cardiology, 1987
- A multicenter trial of doxazosin in West GermanyThe American Journal of Cardiology, 1987
- Efficacy and safety of doxazosin in hypertension therapyThe American Journal of Cardiology, 1987
- The alpha 1‐adrenoceptor antagonist profile of doxazosin: preclinical pharmacology.British Journal of Clinical Pharmacology, 1986
- Doxazosin, an alpha 1‐adrenoceptor antagonist: pharmacokinetics and concentration‐effect relationships in man.British Journal of Clinical Pharmacology, 1983
- Control of blood pressure and reduction of echocardiographically assessed left ventricular mass with one-daily timolol.British Journal of Clinical Pharmacology, 1982
- Reversal of left ventricular hypertrophy in hypertensive patients treated with methyldopa: Lack of association with blood pressure controlThe American Journal of Cardiology, 1982
- ASSESSMENT OF LEFT-VENTRICULAR MASS AND ITS RESPONSE TO ANTIHYPERTENSIVE TREATMENTThe Lancet, 1982
- Postjunctional Selectivity of α-Blockade with Prazosin, Trimazosin, and UK-33,274 in ManJournal of Cardiovascular Pharmacology, 1982